|
HY-B2145-25mg
|
MedChemexpress LLC
|
Ilaprazole (sodium) [CAS 172152-50-0]
|
|
COVID-19-anti-virus
|
|
|
HY-B2145-5mg
|
MedChemexpress LLC
|
Ilaprazole (sodium) [CAS 172152-50-0]
|
|
COVID-19-anti-virus
|
|
|
HY-B2145-50mg
|
MedChemexpress LLC
|
Ilaprazole (sodium) [CAS 172152-50-0]
|
|
COVID-19-anti-virus
|
|
|
HY-B2145-1mL
|
MedChemexpress LLC
|
Ilaprazole (sodium) [CAS 172152-50-0] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
|
HY-101664-10mg
|
MedChemexpress LLC
|
Ilaprazole [CAS 172152-36-2]
|
|
Cancer-programmed cell death
|
|
|
HY-101664-100mg
|
MedChemexpress LLC
|
Ilaprazole [CAS 172152-36-2]
|
|
Cancer-programmed cell death
|
|
|
HY-101664-2mg
|
MedChemexpress LLC
|
Ilaprazole [CAS 172152-36-2]
|
|
Cancer-programmed cell death
|
|
|
HY-101664-5mg
|
MedChemexpress LLC
|
Ilaprazole [CAS 172152-36-2]
|
|
Cancer-programmed cell death
|
|
|
HY-101664-50mg
|
MedChemexpress LLC
|
Ilaprazole [CAS 172152-36-2]
|
|
Cancer-programmed cell death
|
|
|
HY-148870-10mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
|
HY-148870-100mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
|
HY-148870-25mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
|
HY-148870-5mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
|
HY-148870-50mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
|
H2A228-1
|
Virusys Corporation
|
HSV-2, Chicken Polyclonal Antibody
|
Virus
|
ELISA, IF, WB
|
|
